Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.51 -0.11 (-3.18%)
As of: Oct 2, 2026 · 3:19 PM EDT

Lexeo Therapeutics (LXEO) Invested Capital (2023)

Updated

Lexeo Therapeutics (LXEO) recorded Invested Capital of -$158.66 million in Q3 2023.

Analysis

Lexeo Therapeutics (LXEO) Invested Capital (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lexeo Therapeutics 265.74 Mn 265.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -158.66 Mn
API Access

Lexeo Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=LXEO&period=max&api_key=YOUR_API_KEY